Literature DB >> 8812685

Measurements of Natural Killer (NK) Activity and NK-Cell Quantification

.   

Abstract

Natural killer (NK) cells are a subset of lymphocytes with a distinct morphology and the ability to kill certain target cells via one or more cytolytic mechanisms. Measurements of in vitro NK activity from heparinized whole blood, or lymphocytes isolated from human peripheral blood or tissue, may be performed by a variety of techniques. Procedures using standard 51Cr-release assays as well as nonradioactive labeling materials are described in detail in this article, and advantages and disadvantages of these methods are discussed. Quantification of assay results, as percentage of specific lysis, lytic units, and cytolytic units, is explained with attention given to the limitations of each of these calculations. Quality control (QC) procedures that are needed to assure reproducible, reliable NK-cell assays for serial monitoring are described, and suggestions are provided for developing a QC program for these assays. Since NK cells can perform multiple functions, and the mechanism of NK-cell-mediated cytotoxicity is complex, the rationale for selecting a particular assay to measure NK activity is discussed.

Entities:  

Year:  1996        PMID: 8812685     DOI: 10.1006/meth.1996.0037

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  18 in total

1.  TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Authors:  Stephanie C Heidemann; Valerie Chavez; Carol J Landers; Torsten Kucharzik; John L Prehn; Stephan R Targan
Journal:  J Clin Immunol       Date:  2010-03-27       Impact factor: 8.317

2.  Improving methods of assessing natural killer cell cytotoxicity.

Authors:  Sandra E Sephton; Helena C Kraemer; Eric Neri; Daniel P Stites; Inka Weissbecker; David Spiegel
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

3.  Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation.

Authors:  Naoki Kunii; Yangbing Zhao; Shuguang Jiang; Xiaojun Liu; John Scholler; Lakshmi Balagopalan; Lawrence E Samelson; Michael C Milone; Carl H June
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

4.  CD226 protein is involved in immune synapse formation and triggers Natural Killer (NK) cell activation via its first extracellular domain.

Authors:  Shengke Hou; Kuikui Ge; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

5.  Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.

Authors:  Miroslaw J Szczepanski; Marta Szajnik; Ann Welsh; Theresa L Whiteside; Michael Boyiadzis
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

6.  The impact of sleep complaints on physical health and immune outcomes in rescue workers: a 1-year prospective study.

Authors:  Leah A Irish; Angela L Dougall; Douglas L Delahanty; Martica H Hall
Journal:  Psychosom Med       Date:  2013-01-16       Impact factor: 4.312

7.  Suppression of natural killer cell cytotoxicity in postpartum women.

Authors:  Maureen Groer; Nagwa El-Badri; Julie Djeu; Monalisa Harrington; Jeanne Van Eepoel
Journal:  Am J Reprod Immunol       Date:  2010-01-05       Impact factor: 3.886

8.  Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.

Authors:  Jehad Charo; Jan Alvar Lindencrona; Lena-Maria Carlson; Jorma Hinkula; Rolf Kiessling
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Plasma polychlorinated biphenyl concentrations and immune function in postmenopausal women.

Authors:  June T Spector; Anneclaire J De Roos; Cornelia M Ulrich; Lianne Sheppard; Andreas Sjödin; Mark H Wener; Brent Wood; Anne McTiernan
Journal:  Environ Res       Date:  2014-04-11       Impact factor: 6.498

10.  Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Dwight L Evans; Kevin G Lynch; Tami Benton; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David Metzger; Steven D Douglas
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.